You are viewing our development site. Please share feedback with support@dosevault.ai or on our Discord server. See what is new in the changelog.
Information on DoseVault is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment from a qualified healthcare provider.
We use strictly necessary cookies to keep you signed in. With your permission we'd also like to use anonymous analytics to improve the product. See our Cookie Policy and Privacy Policy.
111 compounds across peptides, hormones, and small molecules. 52 have full evidence profiles with mechanism summaries, evidence grades, and peer-reviewed citations. Information is for educational purposes only.
Sort
Compound class
Type
Evidence Grade
WADA Status
WADA status is educational and may change. Athletes are responsible for their own compliance with sport regulations; DoseVault accepts no liability. See the WADA reference for sources and dates.
Showing 23 of 111 compounds (12 with full profiles)
Oral ghrelin-receptor agonist developed for cancer cachexia; approved in Japan as Adlumiz.
Oral non-peptide ghrelin-receptor agonist; FDA-approved as a veterinary appetite stimulant.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) with amino-acid substitutions that extend its plasma half-life.
Synonym/older spelling for Hexarelin; potent GH secretagogue with cardioprotective signaling.
Follistatin is an activin-binding glycoprotein that functions as a natural antagonist of myostatin and activin signaling via TGF-beta family pathways.
Native 44-aa hypothalamic GHRH; parent molecule of sermorelin, CJC-1295, and tesamorelin.
First-generation growth hormone-releasing hexapeptide; precursor to GHRP-2/-6.
GHRP-2 (pralmorelin) is a synthetic hexapeptide growth hormone secretagogue that activates the GHSR-1a receptor, stimulating GH release from the pituitary with greater potency than GHRP-6.
GHRP-6 is a synthetic hexapeptide GH secretagogue that potently stimulates the GHSR-1a receptor (ghrelin receptor), triggering pulsatile GH release.
Gonadorelin binds the GnRH receptor on pituitary gonadotrophs, a Gq-coupled receptor that activates phospholipase C and downstream calcium and PKC signaling to drive synthesis and secretion of LH and FSH.
HCG shares its alpha subunit with LH, FSH, and TSH and carries a distinct beta subunit that binds the LH/hCG receptor with high affinity.
Hexarelin is a synthetic hexapeptide growth hormone secretagogue that acts as a potent GHSR agonist with additional binding at cardiac CD36 receptors.
Growth Hormone Essentials.
Truncated IGF-1 with localized hypertrophic action; favored for site-specific bodybuilding research.
Insulin-like Growth Factor 1 (IGF-1) is a 70-amino-acid single-chain peptide primarily secreted by the liver in response to GH stimulation.
Ipamorelin is a synthetic pentapeptide that acts as a selective growth hormone secretagogue receptor (GHSR) agonist.
Pre-blended GH-stack vial; one injection, both peptides, popular 5+5 mg ratio.
Investigational blend pairing a clean GHRP (ipamorelin) with a stable GHRH (tesamorelin).
Hypothalamic peptide that triggers natural LH surge, a clean alternative to hCG/clomid stim.
IGF-1Ec splice variant released by mechanical loading; activates muscle satellite cells.
MK-677 (Ibutamoren) is an orally active small-molecule GH secretagogue that mimics ghrelin by binding GHSR-1a, stimulating pulsatile GH release and secondarily raising IGF-1.
Sermorelin (GHRH 1-29 NH2) corresponds to the first 29 amino acids of endogenous growth hormone-releasing hormone and has been studied for its ability to stimulate pulsatile GH secretion from the anterior pituitary.
SLU-PP-332 is a synthetic agonist of the estrogen-related receptors (ERR-alpha, beta, gamma), orphan nuclear receptors that regulate mitochondrial biogenesis and oxidative metabolism in skeletal muscle.
